PT Kalbe Farma Tbk 2015 AR2
The report highlights PT Kalbe Farma Tbk's performance in 2015, during which the company achieved a 3.0% growth in net sales to Rp17,887 billion despite a challenging economic environment. Key milestones included the operation of a new oncology factory, marking the first local production of oncology products in Indonesia, and the commencement of a new biopharmaceuticals facility. In addition, Kalbe expanded its digital presence through online stores and mobile applications, and established a strategic joint venture with Blackmores Ltd. Australia to develop the health supplement market. The company also continued its commitment to sustainability through its Kalbe Cares (Kalbe Berbagi) initiatives, investing Rp78 billion in community, health, and environmental programs.
Company: PT Kalbe Farma Tbk
Sector: Health Care
Country: Indonesia
Year: 2015
Type: AR2
Pages: 438
PT Kalbe Farma Tbk
The report highlights PT Kalbe Farma Tbk's performance in 2015, during which the company achieved a 3.0% growth in net sales to Rp17,887 billion despite a challenging economic environment. Key milestones included the operation of a new oncology factory, marking the first local production of oncology products in Indonesia, and the commencement of a new biopharmaceuticals facility. In addition, Kalbe expanded its digital presence through online stores and mobile applications, and established a strategic joint venture with Blackmores Ltd. Australia to develop the health supplement market. The company also continued its commitment to sustainability through its Kalbe Cares (Kalbe Berbagi) initiatives, investing Rp78 billion in community, health, and environmental programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees